Scholarly Index
Sandra M. Swain
Georgetown University; 51,176 total citations; 462 total publications; best world rank #21
Georgetown University
51,176Total citations
462Total publications
87H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Treatment and Pharmacology | Lifetime | 68 | US 39 | 99.75 |
| Breast Cancer Treatment Studies | Lifetime | 81 | US 44 | 99.71 |
| HER2/EGFR in Cancer Research | Lifetime | 65 | US 35 | 99.65 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 21 | US 14 | 99.11 |
| Peptidase Inhibition and Analysis | Lifetime | 204 | US 97 | 99.10 |
| Advanced Breast Cancer Therapies | Lifetime | 75 | US 38 | 99.33 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 505 | US 285 | 99.12 |
| Breast Lesions and Carcinomas | Lifetime | 466 | US 211 | 96.89 |
| Chemotherapy-related skin toxicity | Lifetime | 540 | US 259 | 86.23 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 130 | US 50 | 97.24 |
| Breast Cancer Treatment Studies | 2021-2025 | 138 | US 51 | 98.32 |
| HER2/EGFR in Cancer Research | 2021-2025 | 108 | US 38 | 98.32 |
| Cancer Treatment and Pharmacology | 2021-2025 | 223 | US 76 | 95.58 |
| Advanced Breast Cancer Therapies | 2021-2025 | 246 | US 91 | 95.71 |
| Peptidase Inhibition and Analysis | 2021-2025 | 801 | US 193 | 87.71 |